EsoCap AG has been recognised by the special issue of Life Sciences Review Europe as a top biotech start-up.
“We are extremely pleased to have been chosen for the cover page of Life Sciences Review from the top companies that are at the forefront of providing biotech innovations”, said Isabelle Racamier, EsoCap AG CEO. “This acknowledgement strengthens our resolve to make EsoCap’s highly promising and unique technology a major improvement in the lives of patients”.
